{"authors": [["Sanchez Alberti", "Andr\u00e9s", "A", "Universidad de Buenos Aires, Facultad de Farmacia y Bioqu\u00edmica, C\u00e1tedra de Inmunolog\u00eda and Instituto de Estudios de la Inmunidad Humoral (IDEHU), UBA-CONICET, Buenos Aires, Argentina."], ["Bivona", "Augusto E", "AE", "Universidad de Buenos Aires, Facultad de Farmacia y Bioqu\u00edmica, C\u00e1tedra de Inmunolog\u00eda and Instituto de Estudios de la Inmunidad Humoral (IDEHU), UBA-CONICET, Buenos Aires, Argentina."], ["Cerny", "Natacha", "N", "Universidad de Buenos Aires, Facultad de Farmacia y Bioqu\u00edmica, C\u00e1tedra de Inmunolog\u00eda and Instituto de Estudios de la Inmunidad Humoral (IDEHU), UBA-CONICET, Buenos Aires, Argentina."], ["Schulze", "Kai", "K", "Department of Vaccinology and Applied Microbiology, Helmholtz Center for Infection Research, Braunschweig, Germany."], ["Wei\u00dfmann", "Sebastian", "S", "Department of Vaccinology and Applied Microbiology, Helmholtz Center for Infection Research, Braunschweig, Germany."], ["Ebensen", "Thomas", "T", "Department of Vaccinology and Applied Microbiology, Helmholtz Center for Infection Research, Braunschweig, Germany."], ["Morales", "Celina", "C", "Universidad de Buenos Aires, Facultad de Medicina, Departamento de Patolog\u00eda, Instituto de Fisiopatolog\u00eda Cardiovascular, Buenos Aires, Argentina."], ["Padilla", "Angel M", "AM", "Center for Tropical and Emerging Global Diseases, Athens, GA USA."], ["Cazorla", "Silvia I", "SI", "Universidad de Buenos Aires, Facultad de Farmacia y Bioqu\u00edmica, C\u00e1tedra de Inmunolog\u00eda and Instituto de Estudios de la Inmunidad Humoral (IDEHU), UBA-CONICET, Buenos Aires, Argentina."], ["Tarleton", "Rick L", "RL", "Center for Tropical and Emerging Global Diseases, Athens, GA USA."], ["Guzm\u00e1n", "Carlos A", "CA", "Department of Vaccinology and Applied Microbiology, Helmholtz Center for Infection Research, Braunschweig, Germany."], ["Malchiodi", "Emilio L", "EL", "Universidad de Buenos Aires, Facultad de Farmacia y Bioqu\u00edmica, C\u00e1tedra de Inmunolog\u00eda and Instituto de Estudios de la Inmunidad Humoral (IDEHU), UBA-CONICET, Buenos Aires, Argentina."]], "date": "2017-04-10", "id": "29263868", "text": "The parasite Trypanosoma cruzi is the causative agent of Chagas disease, a potentially life-threatening infection that represents a major health problem in Latin America. Several characteristics of this protozoan contribute to the lack of an effective vaccine, among them: its silent invasion mechanism, T. cruzi antigen redundancy and immunodominance without protection. Taking into account these issues, we engineered Traspain, a chimeric antigen tailored to present a multivalent display of domains from key parasitic molecules, combined with stimulation of the STING pathway by c-di-AMP as a novel prophylactic strategy. This formulation proved to be effective for the priming of functional humoral responses and pathogen-specific CD8+ and CD4+ T cells, compatible with a Th1/Th17 bias. Interestingly, vaccine effectiveness assessed across the course of infection, showed a reduction in parasite load and chronic inflammation in different proof of concept assays. In conclusion, this approach represents a promising tool against parasitic chronic infections.", "doi": "10.1038/s41541-017-0010-z", "title": "Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection.", "journal": ["NPJ vaccines", "NPJ Vaccines"]}